DOLIPRANELIQUIZ 1000 mg, oral suspension in a sachet sweetened with sorbitol, with sucralose and with neohesperidin DC
Active ingredients: Paracetamol
Commercialized according to BDPM
Oral suspension8 sachetspolytéréphtalate (PET) aluminium polyéthylène de 12 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DOLIPRANELIQUIZ 1000 mg, suspension buvable en sachet édulcorée au sorbitol, au sucralose et à la néohespéridine DC
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 8 sachetspolytéréphtalate (PET) aluminium polyéthylène de 12 ml
- Marketing authorisation holder
- OPELLA HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Apr 2022
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69530780CIP73022961CIP133400930229613Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PARACÉTAMOLsuspension | 1000,00 mg · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.